LaKesla R. Iles

The University of Texas MD Anderson Cancer Center

MedicineImmunology and MicrobiologyChemistryBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia”.

Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia

Blood Cancer Journal(2022)10.1038/s41408-022-00675-9

N/A

0.617DataRank · unranked

60 citations

Görkem Kısmalı, LaKesla R. Iles, Ganiraju C. Manyam, Mary Ayres, Lisa S. Chen +5 more

Pharmacological profiling in CLL patients during pirtobrutinib therapy and disease progression

Blood Cancer Journal(2025)10.1038/s41408-025-01382-x

N/A

0.165DataRank · unranked

2 citations

Burcu Aslan, Ganiraju C. Manyam, LaKesla R. Iles, Natalia Timofeeva, Neetu Singh +8 more

Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06316-2

N/A

0DataRank · unranked

4 citations

Moises Tacam, Gaurav B. Chauhan, Evan N. Cohen, Maria Gagliardi, LaKesla R. Iles +13 more

Transcriptomic clustering of chronic lymphocytic leukemia: molecular subtypes based on Bruton’s tyrosine kinase expression levels

Blood Cancer Journal(2024)10.1038/s41408-024-01196-3

N/A

0DataRank · unranked

1 citations

Ganiraju C. Manyam, Nitin Jain, Cristina Ivan, Betty Lamothe, Mary Ayres +4 more

Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0593

N/A

0DataRank · unranked

2 citations

Moises Tacam, Alex W. Tan, Mary Kathryn Pitner, LaKesla R. Iles, Xiaoding Hu +16 more